Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 2;19(3):1681–1686. doi: 10.3892/etm.2020.8411

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Cai et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — Expression level of 25(OH)D in patients with mild, moderate and severe NAFLD. The level of serum 25(OH)D in control group of patients was 19.62±6.07 nmol/l, and those of patients with mild, moderate and severe NAFLD were 17.75±5.71 nmol/l, 15.48±3.52 nmol/l and 13.61±5.38 nmol/l, respectively. The level of 25(OH)D in patients with mild, moderate and severe NAFLD was significantly lower than that in the control group (P<0.05). Patients with different severity in NAFLD group were compared. The level of 25(OH)D in patients with moderate and severe NAFLD was significantly lower than that of patients with mild NAFLD (P<0.05). That of patients with severe NAFLD was significantly lower than of patients with moderate NAFLD (P<0.05). *P<0.05, compared with the mild NAFLD group; #P<0.05, compared with the moderate NAFLD group.